Technology News and Research

RSS

Dual thermal ablation can kill pancreatic cancer cells, research shows

A heating and freezing process known as dual thermal ablation can kill pancreatic cancer cells, according to new research from Binghamton University, State University at New York.

27 Feb 2018

Phasefocus™ appoints Australian distributor as part of expansion

The appointment of ATA Scientific Instruments as the official distributor for Phasefocus™ in Australia and New Zealand marks the latest step in the Imaging and microscopy businesses global expansion plan.

From Phase Focus Limited 26 Feb 2018

Hamilton Robotics Launch ID NIMBUS® for Forensic Genomics Applications

Hamilton Robotics announce the release of the ID NIMBUS® assay ready workstation, specifically pre-configured and qualified to automate post-PCR sample processing using the Verogens renowned ForenSeq DNA Signature Prep Kit.

From Hamilton Process Analytics 26 Feb 2018

Researchers demonstrate novel process to produce cell-sized lipid vesicles

A team of researchers at the University of California in Irvine, California has demonstrated a novel process to produce cell-sized lipid vesicles (CLVs) from microfluidically generated double emulsion templates by investigating the interfacial parameters that control double emulsion stability for storage, and their subsequent dewetting to form multisomes or GUVs (subsets of CLVs).

24 Feb 2018

New research project to determine why mine dust-related lung diseases are on the rise

The passage of critical mine health and safety legislation in the late 1960s, along with advances in technology and safety practices, helped to decrease the prevalence of lung diseases for miners. But starting in the mid-1990s, there was a significant documented increase in lung diseases among coal workers, especially among younger workers.

24 Feb 2018

Visaris Americas announces installation of fully robotic Vision C digital X-ray suite at OGHS

Visaris Americas, is an innovative provider of digital radiography (DR) technology for the medical diagnostics market. Together with Ultimate Medical Services, their preferred channel partner in the South-Central States; the Company is proud to announce the installation of its premium, fully robotic, Vision C ceiling-suspended digital X-ray suite at the Opelousas General Health System, South Campus location in Opelousas, Louisiana.

24 Feb 2018

New low-cost microfluidic device brings single-cell technology to bedside

Single-cell analysis holds enormous potential to study how individual cells influence disease and respond to treatment, but the lack of cost-effective and user-friendly instrumentation remains challenging.

23 Feb 2018

Cell therapy for heart disease caused by muscular dystrophy also improves limb strength, study shows

Injections of cardiac progenitor cells help reverse the fatal heart disease caused by Duchenne muscular dystrophy and also lead to improved limb strength and movement ability, a new study shows.

23 Feb 2018

New discovery could accelerate clinical translation of stem cell-based therapies

A team of scientists from the University of Colorado School of Medicine and the Charles C. Gates Center for Regenerative Medicine at CU Anschutz has reported a more efficient approach to reprogramming a patient's diseased skin cells into stem cells, raising hopes for future clinical trials and potential cures for critical illnesses.

23 Feb 2018

UNIST researchers introduce new biosensing contact lens for diabetics

A team of researchers, affiliated with UNIST has recently introduced a new biosensing contact lens capable of detecting glucose levels in patients with diabetes.

22 Feb 2018

3D Signatures reports positive results of new Telo-HL test for Hodgkin's lymphoma

3D Signatures Inc. is pleased to announce that a preliminary third-party analysis of the trial data for Telo-HL, 3DS' test in development for Hodgkin's lymphoma (HL), shows that the Company's TeloViewTM platform is able to distinguish, with a high degree of statistical significance, multiple differences between a patient group that responds to standard ABVD chemotherapy, and a group that relapses or is refractory to treatment within the first 12 months.

22 Feb 2018

MED-EL introduces new revolutionary surgical planning software

MED-EL Medical Electronics, global manufacturer of hearing implant systems and solutions, and CAScination, specialists in surgical navigation solutions and medical robots, have today announced the launch of a revolutionary surgical planning software at the 31st Politzer Society meeting in Gran Canaria.

From MED-EL UK Ltd 22 Feb 2018

Local environment plays crucial role in aggressiveness of breast cancer

Breast cancer is the most commonly diagnosed cancer in women -- one in eight (12.4 percent) in the U.S. will be diagnosed with it. Invasive breast cancer is dangerous for two reasons: It can aggressively spread to other organs in the body, and it is likely to recur.

21 Feb 2018